Ann Intern Med

1. CENTOR RM, Tenforde MW, Dawood FS
   Web Exclusive. Annals On Call - Encouraging Influenza Vaccination.
   Ann Intern Med. 2024;177:eA230004.
   

   >> Share

   
   
2. WU Q, Tong J, Zhang B, Zhang D, et al
   Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents.
   Ann Intern Med. 2024 Jan 9. doi: 10.7326/M23-1754.
   

   >> Share

   
   
3. TROY AL, Ahmad I, Zheng Z, Wadhera RK, et al
   Food Insecurity Among Low-Income U.S. Adults During the COVID-19 Pandemic.
   Ann Intern Med. 2024 Jan 2. doi: 10.7326/M23-2282.
   

   >> Share

   
   
4. WOLFSON JA, Leung CW
   Food Insecurity in the COVID-19 Era: A National Wake-up Call to Strengthen SNAP Policy.
   Ann Intern Med. 2024 Jan 2. doi: 10.7326/M23-3363.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

5. PLOTNIK D, Sager JE, Aryal M, Fanget MC, et al
   A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness.
   Antimicrob Agents Chemother. 2024 Feb 20:e0127323. doi: 10.1128/aac.01273.
   

   >> Share

   
   

   
   BMJ

6. WORSHAM CM, Bray CF, Jena AB
   Optimal timing of influenza vaccination in young children: population based cohort study.
   BMJ. 2024;384:e077076.
   

   >> Share

   
   
7. WISE J
   GMC admits error in decision over whether to investigate doctor's claims over covid vaccine.
   BMJ. 2024;384:q433.
   

   >> Share

   
   
8. LEMASTERS K, Brinkley-Rubinstein L
   Covid-19 in US jails and prisons: implications for the next public health crisis.
   BMJ. 2024;384:e076975.
   

   >> Share

   
   

   
   Drug Saf

9. WYSZYNSKI DF, Papageorghiou AT, Renz C, Metz TD, et al
   The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol Considerations.
   Drug Saf. 2024;47:195-204.
   

   >> Share

   
   

   
   Epidemiol Infect

10. GARAY E, Whelan SPJ, DuBois RM, O'Rourke SM, et al
    Immune response to SARS-CoV-2 variants after immunization with different vaccines in Mexico.
    Epidemiol Infect. 2024;152:e30.
    

    >> Share

    
    

    
    J Immunol

11. AL-AHMAD A
    Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
    J Immunol. 2024;212:753.
    

    >> Share

    
    
12. MAINO A, Amen A, Plumas J, Bouquet L, et al
    Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for the Expansion and Characterization of SARS-CoV-2-Specific T Cells.
    J Immunol. 2024;212:825-833.
    

    >> Share

    
    

    
    J Infect Dis

13. MAKHSOUS N, Goya S, Avendano CC, Rupp J, et al
    Within-Host Rhinovirus Evolution in Upper and Lower Respiratory Tract Highlights Capsid Variability and Mutation-Independent Compartmentalization.
    J Infect Dis. 2024;229:403-412.
    

    >> Share

    
    
14. KARRON RA, Luongo C, Woods S, Oliva J, et al
    Evaluation of the live-attenuated intranasal respiratory syncytial virus (RSV) vaccine RSV/6120/DeltaNS2/1030s in RSV-seronegative young children.
    J Infect Dis. 2023 Jul 26:jiad281. doi: 10.1093.
    

    >> Share

    
    
15. HEIMONEN J, Chow EJ, Wang Y, Hughes JP, et al
    Risk of Subsequent Respiratory Virus Detection After Primary Virus Detection in a Community Household Study-King County, Washington, 2019-2021.
    J Infect Dis. 2024;229:422-431.
    

    >> Share

    
    
16. LEROUX-ROELS I, Van Ranst M, Vandermeulen C, Abeele CV, et al
    Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study.
    J Infect Dis. 2023 Sep 12:jiad321. doi: 10.1093.
    

    >> Share

    
    
17. MADSEN AMR, Schaltz-Buchholzer F, Nielsen S, Benfield T, et al
    Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: a randomized controlled trial.
    J Infect Dis. 2023 Sep 29:jiad422. doi: 10.1093.
    

    >> Share

    
    
18. MONROE JM, Quach HQ, Punia S, Enninga EAL, et al
    Vertical Transmission of SARS-CoV-2-Specific Antibodies and Cytokine Profiles in Pregnancy.
    J Infect Dis. 2024;229:473-484.
    

    >> Share

    
    
19. CASADEVALL A, Sullivan DJ
    Late Administration and Corticosteroid Usage Explain Inefficacy in COVID-19 Convalescent Plasma Trial.
    J Infect Dis. 2024;229:617-618.
    

    >> Share

    
    
20. KANBERG N, Grahn A, Stentoft E, Bremell D, et al
    COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.
    J Infect Dis. 2024;229:493-501.
    

    >> Share

    
    
21. TURCINOVIC J, Kuhfeldt K, Sullivan M, Landaverde L, et al
    Transmission Dynamics and Rare Clustered Transmission Within an Urban University Population Before Widespread Vaccination.
    J Infect Dis. 2023 Oct 19:jiad397. doi: 10.1093.
    

    >> Share

    
    
22. YOUNG BR, Ho F, Lin Y, Lau EHY, et al
    Estimation of the Time-Varying Effective Reproductive Number of COVID-19 Based on Multivariate Time Series of Severe Health Outcomes.
    J Infect Dis. 2024;229:502-506.
    

    >> Share

    
    
23. VUJKOVIC A, Ha M, de Block T, van Petersen L, et al
    Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells.
    J Infect Dis. 2024;229:507-516.
    

    >> Share

    
    
24. GREWAL R, Buchan SA, Nguyen L, Nasreen S, et al
    Effectiveness of mRNA COVID-19 monovalent and bivalent vaccine booster doses against Omicron severe outcomes among adults aged >/=50 years in Ontario, Canada: a Canadian Immunization Research Network (CIRN) Study.
    J Infect Dis. 2023 Oct 5:jiad419. doi: 10.1093.
    

    >> Share

    
    
25. ADHIKARI EH, Lu P, Kang YJ, McDonald AR, et al
    Diverging maternal and cord antibody functions from SARS-CoV-2 infection and vaccination in pregnancy.
    J Infect Dis. 2023 Oct 10:jiad421. doi: 10.1093.
    

    >> Share

    
    
26. HSU FC, Pan LC, Huang YF, Yang CH, et al
    A Dynamic Model for Estimating the Retention Duration of Neutralizing Antibody Titers after Vaccination in a COVID-19 Convalescent Population.
    J Infect Dis. 2023 Oct 5:jiad431. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol

27. HSIEH M-S, Hsu C-W, Liao H-C, Lin C-L, et al
    SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
    J Virol. 2024 Feb 1:e0154623. doi: 10.1128/jvi.01546.
    

    >> Share

    
    
28. SHEN S, Guo H, Li Y, Zhang L, et al
    SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis.
    J Virol. 2024 Jan 30:e0190923. doi: 10.1128/jvi.01909.
    

    >> Share

    
    
29. UPRETY T, Yu J, Nogales A, Naveed A, et al
    Influenza D virus utilizes both 9-O-acetylated N-acetylneuraminic and 9-O-acetylated N-glycolylneuraminic acids as functional entry receptors.
    J Virol. 2024 Feb 20:e0004224. doi: 10.1128/jvi.00042.
    

    >> Share

    
    

    
    Lancet

30. VORA NM, Hassan L, Plowright RK, Horton R, et al
    The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention.
    Lancet. 2024;403:597-599.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

31. MUSA N, Ghoniem A, Hsu CH, Mubarak S, et al
    Progress Toward Measles Elimination - World Health Organization Eastern Mediterranean Region, 2019-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:139-144.
    

    >> Share

    
    
32. FORD ND, Agedew A, Dalton AF, Singleton J, et al
    Notes from the Field: Long COVID Prevalence Among Adults - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:135-136.
    

    >> Share

    
    
33. EDENS C, Clopper BR, DeVies J, Benitez A, et al
    Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:149-151.
    

    >> Share

    
    

    
    N Engl J Med

34. BENEZECH S, Khoryati L, Belot A
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C. Reply.
    N Engl J Med. 2024;390:771-772.
    

    >> Share

    
    
35. FRANCO A, Tremoulet A, Burns JC
    More on Pre-Covid-19, SARS-CoV-2-Negative MIS-C.
    N Engl J Med. 2024;390:771.
    

    >> Share

    
    
36. HERBERT C, McManus DD, Soni A
    Persistent False Positive Covid-19 Rapid Antigen Tests.
    N Engl J Med. 2024;390:764-765.
    

    >> Share

    
    

    
    PLoS Comput Biol

37. LAMB KD, Luka MM, Saathoff M, Orton RJ, et al
    Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules.
    PLoS Comput Biol. 2024;20:e1011795.
    

    >> Share

    
    

    
    PLoS Med

38. NICKEL NC, Phillips-Beck W, Enns JE, Ekuma O, et al
    COVID-19 diagnostic testing and vaccinations among First Nations in Manitoba: A nations-based retrospective cohort study using linked administrative data, 2020-2021.
    PLoS Med. 2024;21:e1004348.
    

    >> Share

    
    

    
    PLoS One

39. PELLETIER C, Gagnon D, Dube E
    "It's not that I don't trust vaccines, I just don't think I need them": Perspectives on COVID-19 vaccination.
    PLoS One. 2024;19:e0293643.
    

    >> Share

    
    
40. RUCHIWIT P, Madua J, Saiphoklang N
    Comparison of ROX, HROX, and delta-HR indices to predict successful weaning from high-flow oxygen therapy in hospitalized patients with COVID-19 pneumonia.
    PLoS One. 2024;19:e0297624.
    

    >> Share

    
    
41. TAKEBAYASHI M, Namba M, Kaneda Y, Koyama T, et al
    How can we promote vaccination of the mass population?-Lessons from the COVID-19 vaccination defaults.
    PLoS One. 2024;19:e0298983.
    

    >> Share

    
    
42. ELBEJJANI M, Mansour S, Hammoud RA, Ziade C, et al
    Mental health during the COVID-19 pandemic and first lockdown in Lebanon: Risk factors and daily life difficulties in a multiple-crises setting.
    PLoS One. 2024;19:e0297670.
    

    >> Share

    
    
43. WEISE V, Guttner F, Staudt A, Mack JT, et al
    Relationship satisfaction and family routines of young parents before and during the first year of the COVID-19 pandemic: A latent growth curve analysis.
    PLoS One. 2024;19:e0297740.
    

    >> Share

    
    
44. BASHIR MA, Awoonor-Williams JK, Amponsah-Manu F
    Prevalence of fever and its associated risk factors among patients hospitalised with coronavirus disease 2019 (COVID-19) at the Eastern Regional Hospital, Koforidua, Ghana.
    PLoS One. 2024;19:e0296134.
    

    >> Share

    
    
45. BEN-UMEH KC, Kim J
    Income disparities in COVID-19 vaccine and booster uptake in the United States: An analysis of cross-sectional data from the Medical Expenditure Panel Survey.
    PLoS One. 2024;19:e0298825.
    

    >> Share

    
    
46. BALEGHA AN, Abdul-Aziz S, Mornah L
    Healthcare professionals' perception and COVID-19 vaccination attitudes in North-Western Ghana: A multi-center analysis.
    PLoS One. 2024;19:e0298810.
    

    >> Share

    
    
47. BRADY SM, Salway R, Mariapun J, Millard L, et al
    Accelerometer-measured 24-hour movement behaviours over 7 days in Malaysian children and adolescents: A cross-sectional study.
    PLoS One. 2024;19:e0297102.
    

    >> Share

    
    
48. JEONG HS, Chun BC
    COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    PLoS One. 2024;19:e0297902.
    

    >> Share

    
    
49. YAFFE MJ, McCusker J, Lambert SD, Haggerty J, et al
    Self-care interventions to assist family physicians with mental health care of older patients during the COVID-19 pandemic: Feasibility, acceptability, and outcomes of a pilot randomized controlled trial.
    PLoS One. 2024;19:e0297937.
    

    >> Share

    
    
50. ROSEN J, Frykholm P, Jonsson Fagerlund M, Pellegrini M, et al
    Lung impedance changes during awake prone positioning in COVID-19. A non-randomized cross-over study.
    PLoS One. 2024;19:e0299199.
    

    >> Share

    
    
51. ADINKRAH EK, Bazargan S, Cobb S, Kibe LW, et al
    Mobilizing faith-based COVID-19 health ambassadors to address COVID-19 health disparities among African American older adults in under-resourced communities: A hybrid, community-based participatory intervention.
    PLoS One. 2024;19:e0285963.
    

    >> Share

    
    
52. LEGGETT H, Vinall-Collier K, Csikar J, Barber S, et al
    Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio.
    PLoS One. 2024;19:e0296343.
    

    >> Share

    
    
53. TINJIC D, Norden A
    Crisis-driven digitalization and academic success across disciplines.
    PLoS One. 2024;19:e0293588.
    

    >> Share

    
    
54. SHAIK M, Rabbani MR, Atif M, Aysan AF, et al
    The dynamic volatility nexus of geo-political risks, stocks, bond, bitcoin, gold and oil during COVID-19 and Russian-Ukraine war.
    PLoS One. 2024;19:e0286963.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

55. RAINS SA, Richards AS
    US state vaccine mandates did not influence COVID-19 vaccination rates but reduced uptake of COVID-19 boosters and flu vaccines compared to bans on vaccine restrictions.
    Proc Natl Acad Sci U S A. 2024;121:e2313610121.
    

    >> Share

    
    

    
    Vaccine

56. KOLANDAI K, Milne B, von Randow M, Bullen C, et al
    Public opinion on global COVID-19 vaccine procurement and distribution policies: A nationally representative survey in Aotearoa New Zealand 2022.
    Vaccine. 2024 Feb 6:S0264-410X(24)00115-4. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
57. MIYAMOTO S, Suzuki T
    Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development.
    Vaccine. 2024 Feb 2:S0264-410X(24)00112-9. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
58. BENNETT JC, Luiten KG, O'Hanlon J, Han PD, et al
    Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection.
    Vaccine. 2024 Feb 1:S0264-410X(24)00103-8. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
59. DATTA S, Vattiato G, Maclaren OJ, Hua N, et al
    The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study.
    Vaccine. 2024 Feb 1:S0264-410X(24)00128-2. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
60. SOOD S, Matar MM, Kim J, Kinsella M, et al
    Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer.
    Vaccine. 2024 Jan 31:S0264-410X(24)00077-X. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
61. JI Y, Sui X, Miao W, Wang C, et al
    Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model.
    Vaccine. 2024 Jan 30:S0264-410X(24)00097-5. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
62. SHAPIRO BEN DAVID S, Baruch Gez S, Adler L, Kovatch R, et al
    Short term safety of BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine among children aged 5-11 years, a nationwide parental survey.
    Vaccine. 2024 Jan 27:S0264-410X(24)00067-7. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
63. BALSELLS E, Vicente M, Reyes S, Figueroa M, et al
    Impact of the 'Health on Wheels' (HoW) strategy on COVID-19 vaccination coverage in hard-to-reach communities in Alta Verapaz, Guatemala, 2022.
    Vaccine. 2024 Jan 27:S0264-410X(24)00033-1. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
64. OKPANI AI, Adu P, Paetkau T, Lockhart K, et al
    Are COVID-19 vaccination mandates for healthcare workers effective? A systematic review of the impact of mandates on increasing vaccination, alleviating staff shortages and decreasing staff illness.
    Vaccine. 2024 Jan 27:S0264-410X(24)00052-5. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
65. TAKALANI A, Robinson M, Jonas P, Bodenstein A, et al
    Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa.
    Vaccine. 2024 Jan 25:S0264-410X(24)00078-1. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
66. RUSS S, Bennett N, van Wijngaarden E, Hill E, et al
    Influence of Community Determinants on Barriers and Facilitators to COVID-19 Vaccine Uptake: Regional Stakeholders' Perspectives.
    Vaccine. 2024 Jan 24:S0264-410X(24)00051-3. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
67. HAMAD SAIED M, van Straalen JW, de Roock S, Verduyn Lunel FM, et al
    Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases: A prospective cohort study.
    Vaccine. 2024 Jan 22:S0264-410X(24)00059-8. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
68. PAL R, Ferrari MG, Honda-Okubo Y, Wattay L, et al
    Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates.
    Vaccine. 2024 Jan 22:S0264-410X(24)00034-3. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
69. HILL PL, Morstead T, Pfund GN, Burrow AL, et al
    Examining changes in sense of purpose before, during, and after COVID-19 vaccination.
    Vaccine. 2024 Jan 20:S0264-410X(24)00027-6. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
70. KING ML
    How manufacturing won or lost the COVID-19 vaccine race.
    Vaccine. 2024 Jan 15:S0264-410X(23)01477-9. doi: 10.1016/j.vaccine.2023.
    

    >> Share

    
    
71. HINSON-ENSLIN AM, Espinoza LE
    The mental health symptoms of individuals with sensory disabilities and the reasons that lead to COVID-19 vaccine refusal and hesitancy.
    Vaccine. 2024 Jan 9:S0264-410X(24)00012-4. doi: 10.1016/j.vaccine.2024.
    

    >> Share

    
    
72. MESIDOR M, Liu Y, Talbot D, Skowronski DM, et al
    Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review.
    Vaccine. 2023 Dec 9:S0264-410X(23)01446-9. doi: 10.1016/j.vaccine.2023.
    

    >> Share

    
    
73. SATHE N, Shaikh S, Bhavsar M, Parte L, et al
    Safety, immunogenicity and efficacy of Relcovax(R), a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus.
    Vaccine. 2023 Oct 8:S0264-410X(23)01176-3. doi: 10.1016/j.vaccine.2023.
    

    >> Share

    
    

    
    Virology

74. ALTINA NH, Maranon DG, Anderson JR, Donaldson MK, et al
    The leader RNA of SARS-CoV-2 sequesters polypyrimidine tract binding protein (PTBP1) and influences pre-mRNA splicing in infected cells.
    Virology. 2024;592:109986.
    

    >> Share

    
    
75. VALLERIANI F, Di Pancrazio C, Spedicato M, Di Teodoro G, et al
    A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice.
    Virology. 2024;592:109997.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share